Table 1.
Study | Region Studied | No. of Patients | Age Group of COVID-19 Patients, y, median (IQR) | No. of Patients With HBV | Hepatitis B Rate, % | ||
---|---|---|---|---|---|---|---|
COVID-19 Patients | Region | Similar Age Group in Region | |||||
Zhao et al [6] | Anhui, China | 19 | 48 (27–56) | 1 | 5.26 | 7.44 | 7.5–9a |
Guan et al [7] | China | 1099 | 47 (35–58) | 23 | 2.1 | 6.89 | ~5.5–7a |
Chen et al [8] | Wuhan, China | 99 | 55.5 (36–64) | 0 | 0 | 6.89b | ~5.5–7b |
Xu et al [9]c | Wuhan, China | 62 | 41 (32–52) | 2 | 3.22 | 6.89b | ~5.5–7b |
Chen et al [10] | Shanghai, China | 249 | 51 (36–64) | 2 | 0.8 | 7.2 | 8.3–8.7a |
Young et al [11]c | Singapore | 18 | 47 (31–71) | 0 | 0 | 3.6 | ~4.1a |
Pan et al (in press) | Hubei, China | 204 | 52.9 (SD, 16) | 0 | 0 | 9.2 | 11.1a |
Abbreviations: COVID-19, coronavirus disease 2019; HBV, hepatitis B virus; SD, standard deviation.
bNo data specific to the Wuhan area were noted and so general rates in China were used here.
cPersonal communication from the authors.